How to Fight Medicare Fraud & Protect your Identity

Breaking News
940

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Happy National Consumer Protection Week! Now’s a great time to brush up on your Medicare rights and protections, and take action to protect your identity.

Here are 3 things to do:

  1. Protect your identity. Identity theft happens when someone uses your personal information without your consent to commit fraud or other crimes. Guard your Medicare Number and card, and keep your Social Security Number safe.
  2. Help fight Medicare fraud. Use your MyMedicare account to stay on top of your claims. If you find errors or fraud, report it to us. Don’t have a MyMedicare account yet? Sign up for free at MyMedicare.govtoday.
  3. Know your rights. You have certain rights and protections designed to make sure you get the health care services the law says you can get.

Sincerely, The Medicare Team

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Ophthalmologist Surgeon Revolutionizing Cornea Transplants in the Valley
Next article
‘If They can Dream, They can Achieve’: STC Instructor Hoping to Inspire others by Sharing Personal Story of Earning Healthcare Degree later in Life

More Articles

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -